Straumann Holding AG (FRA:QS51) 3-Year Revenue Growth Rate : 19.10% (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Straumann Holding AG 3-Year Revenue Growth Rate?

Straumann Holding AG's Revenue per Share for the six months ended in Dec. 2023 was €7.94.

During the past 12 months, Straumann Holding AG's average Revenue per Share Growth Rate was 3.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 19.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 13.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 14.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Straumann Holding AG was 22.50% per year. The lowest was -3.90% per year. And the median was 13.20% per year.

Competitive Comparison of Straumann Holding AG's 3-Year Revenue Growth Rate

For the Medical Instruments & Supplies subindustry, Straumann Holding AG's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Straumann Holding AG's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Straumann Holding AG's 3-Year Revenue Growth Rate falls into.

Straumann Holding AG 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Straumann Holding AG (FRA:QS51) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Straumann Holding AG 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Straumann Holding AG's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Straumann Holding AG (FRA:QS51) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Straumann Holding AG (FRA:QS51) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

SAUHY:USA SAUHF:USA STMNz:UK 0QMV:UK STMN:Switzerland

Address

Peter Merian-Weg 12, Basel, CHE, 4002

Website

https://www.straumann-group.com

Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company's core products are dental implants, and it holds roughly 30% of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

Straumann Holding AG (FRA:QS51) Headlines

No Headlines